ACI Welcomes FSA’s 11 March CBD Novel Foods Update
ACI welcomes the recent update from the UK’s Food Standards Agency concerning the criteria of which CBD products can remain on sale in the UK as of 1st April 2021.
ACI Submits Novel Foods Application to FSA on Behalf of CBD Safety Consortium
ACI have submitted their novel food application on behalf of the members of our CBD Safety Study Consortium. This marks a pivotal milestone for the ACI, whose members have been diligently working to meet the compliance deadline set by the UK’s Food Standards Agency (FSA).
ACI in Ongoing Discussions with European Commission Relating to Novel Foods
With the European Commission (EC) stating that they will begin assessing novel food dossiers on CBD again, ACI started 2021 by engaging the EC in constructive dialogue regarding our consortium approach to novel food applications.
[BusinessCann] Compliant CBD Companies Call For Crackdown On UK’s Novel Food ‘Refuseniks’
After cumulatively spending tens of millions of pounds on Novel Food compliance many UK CBD companies may be left feeling frustrated come the end of March deadline.
On April 1. the much-touted and controversial Novel Food rules come into place for businesses in the CBD supply chain.
[Video] CBD 2021: The UK Opportunity
On 31 March 2021, guidelines set by the UK Foods Standards Agency (FSA) will come into effect and transform the CBD market, which is projected to be worth £1billion by 2025. In this 9 minutes long video you will learn from the experts in this space.
[NutraIngredients] Food Standards Scotland CBD position at odds with stance of UK counterpart
Food Standards Scotland (FSS) has sought to clarify its position concerning the sale of CBD-related products, in a stance that clashes with the opinion set out by the UK Food Standards Authority (FSA).
[NutritionInsight] Holiday Roundup – In Brief: Regulation
NutritionInsight provides an overview of the various business developments over the holiday period and includes the clarification ACI received from FSS on their stance on CBD.
[Food Navigator] ‘A Christmas wish come true’: CBD industry celebrates as EC resumes Novel Food applications
More good news for the CBD industry. The European Commission has abandoned its plans to classify non-synthetic CBD a narcotic and resumed Novel Food applications for edible CBD products.
The move came after the European Court of Justice ruled that CBD is not a narcotic drug as it “does not appear to have any psychotropic effect or any harmful effect on human health”.
Food Standards Scotland Clarifies Their CBD Position to ACI and Our Members
Food Standards Scotland (FSS) clarified their position in relation to CBD in food products to the ACI. They emphasised, from a legal perspective, ingredients which are classified as novel foods are not permissible on the market until they have a full novel foods authorisation. However, they support a proportionate response by local authorities based on a companies commitment to gaining novel foods authorisation.
[Food Navigator] ‘A breakthrough for the market’: Europe’s highest court rules CBD is not a narcotic
Europe’s CBD market is optimistic a ruling from the EU’s highest court not to classify the ingredient a narcotic – going against the European Commission’s shock preliminary view in July – will pave the way for Novel Food applications for CBD products to re-start.
The Court of Justice of the European Union ruled CBD is not a narcotic drug as it “does not appear to have any psychotropic effect or any harmful effect on human health”.
